最新发布
NativeSeed Group Acquires Assets of Sharp Brothers Seed Company to Expand Native Seed Processing Across Great Plains
By Editor, AgInvesting Media NativeSeed Group has acquired the assets of Sharp Brothers Seed Company, a long-standing sp…
Global Outlook on the Agriculture Industry: Insights from GAI Europe
By Editor, AgInvesting Media The agricultural sector continues to navigate a changing economic environment marked by shi…
U.S. Endowment Commits $5 Million to New Venture Capital Fund to Accelerate Forest Innovation
By Editor, AgInvesting Media In an effort to address early-stage funding gaps within timberland and natural capital mark…
The food industry is absorbing shocks so well that nobody is pricing the risk
“We’re almost living at the least extreme temperature that we’re going to experience in our lifetime,&…
The Casualties of the Agritech Boom
2 As agritech has grown across Africa and the global stage, so has the number of ambitious startups trying to solve crit…
AgriFood Signals: Cargill & Klim team up, Starbucks ditches Impossible, farmland manager Red Reef scores $263m
AgFunderNews rounds up the most important fundings, mergers, acquisitions, closures, and industry buzz in agtech and foo…
Why Fintech Continues to Outshine Agritech in Africa
9 The funding gap between fintech and agritech goes well beyond Africa. Historically, financial technology has attracted…
Miyoko’s comeback off to rocky start amid recalls, recipe changes. Problems are ‘temporary,’ says new owner
The embattled new owner of Miyoko’s Creamery has acknowledged some teething problems as the brand has switched to new c…
A cybersecurity checklist for the animal protein industry
Bad actors armed with AI have kept busy this year attacking critical infrastructure like wastewater pumps and supermarke…
argenx buys macrocycle partner Unnatural Products for up to $1.15 billion
Why it matters: The acquisition adds a new drug modality to argenx’s antibody-focused discovery capabilities, potentially enabling oral and longer-acting treatments for autoimmune diseases. It also marks another major acquisition this year, following the $2.2 billion purchase of Forte Biosciences.